Pharmaceutical Technology-01-02-2004

Two FDA final rules issued in response to the Bioterrorism Response Act of 2002 may significantly affect the supply and importation of pharmaceutical excipients.

As manufacturers move to manufacture to demand rather than to forecast, the traditional wholesaling business model is being transformed.